Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Medical Genetics

The Wide Spectrum of Symptoms and Variability in SLOS

At a Glance

Smith-Lemli-Opitz Syndrome (SLOS) presents a broad spectrum of symptoms ranging from mild to severe. Key signs include webbed toes, a smaller head size, sleep disturbances, and behavioral challenges like irritability. The severity is closely linked to the body's ability to produce cholesterol.

One of the most challenging aspects of a Smith-Lemli-Opitz Syndrome (SLOS) diagnosis is the sheer variety of ways it can appear in different individuals. Doctors refer to this as a broad clinical spectrum, meaning that the condition can range from very mild symptoms that are barely noticeable until adulthood, to severe, life-threatening complications present at birth [1][2]. Understanding this variability is key to advocating for specific support needs.

Hallmark Physical Features

While everyone is unique, several physical signs are considered “hallmarks” of SLOS. These features often provide the first clues for doctors to begin testing.

  • 2,3 Toe Syndactyly: This is a very common sign where there is partial webbing or fusing of the skin between the second and third toes [1][3]. It does not usually affect the ability to walk, but it is a distinct marker for the syndrome.
  • Microcephaly: This is a medical term for a head size that is smaller than expected for a person’s age and sex [1][4]. It occurs because the brain may not grow at a typical rate due to the lack of cholesterol.
  • Facial Dysmorphism: Individuals with SLOS may share certain facial characteristics, such as a small upturned nose, drooping eyelids (ptosis), and low-set or folded ears [5][6].
  • Cleft Palate: Some are born with an opening in the roof of the mouth, which can affect feeding and speech [7].

The Spectrum of Severity

The severity of SLOS is often linked to biochemical levels—specifically, how much cholesterol the body can produce and how much 7-DHC (the precursor) builds up [8][9].

  • Mild Phenotype: Some individuals have near-normal development. They may have the hallmark webbed toes and minor learning challenges but can attend school and lead relatively independent adult lives [10][1].
  • Classic/Severe Phenotype: On the other end of the spectrum, individuals may face significant internal malformations (affecting the heart, kidneys, or genitalia), severe feeding difficulties, and profound intellectual disabilities [2][7].

Neurodevelopment and Behavior

The brain requires a significant amount of cholesterol to function, so neurodevelopmental challenges are a central part of SLOS [11].

Behavioral Challenges

Irritability is one of the most frequently reported symptoms in the SLOS community [12]. Parents often describe their children as being “difficult to soothe,” and adults may struggle with emotional regulation. In some cases, individuals may engage in self-injurious behavior, such as head banging or hand biting, which requires specialized behavioral support [13].

Sleep Disturbances

Sleep is a major hurdle. Research has shown a direct link between cholesterol levels and sleep quality; those with SLOS often experience frequent night wakings and difficulty falling asleep [14].

Autism-Like Traits

Many individuals with SLOS exhibit behaviors similar to Autism Spectrum Disorder (ASD), such as repetitive motions or difficulty with social communication [9]. However, it is important to note that developmental delays can sometimes make “autism scores” look higher than they actually are. Interestingly, individuals with SLOS often have better receptive language (understanding what is said) than expressive language (the ability to speak) [15]. This validates that comprehension is often much stronger than verbal output.

Why Variability Exists

Even within the same family, two individuals with the exact same genetic mutation can have very different symptoms [10]. While certain “missense mutations” are generally associated with milder cases, doctors cannot always predict the future based on genetics alone [16]. This is why integrated, multidisciplinary care is essential to address specific physical and behavioral needs [17].

Common questions in this guide

What are the physical signs of Smith-Lemli-Opitz syndrome?
Common physical hallmarks of SLOS include partial webbing between the second and third toes, a smaller than expected head size (microcephaly), distinct facial features, and sometimes a cleft palate.
Why do SLOS symptoms vary so much between patients?
The severity of SLOS is closely linked to how much cholesterol the body can produce and the buildup of its precursor, 7-DHC. Even individuals with the exact same genetic mutation can experience very different symptom severities.
Are behavioral issues common in children with SLOS?
Yes, behavioral challenges are a central part of the condition because the brain requires cholesterol to function properly. Individuals often experience significant irritability, sleep disturbances, and sometimes self-injurious behaviors that require specialized support.
Does SLOS cause autism?
Many individuals with SLOS exhibit autism-like traits, such as repetitive motions or challenges with social communication. Interestingly, individuals with SLOS often have a much stronger ability to understand language than to speak it.
Why do children with SLOS have trouble sleeping?
Frequent night wakings and difficulty falling asleep are very common in SLOS. Research links these sleep disturbances directly to the altered cholesterol levels in the brain.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given current cholesterol levels and symptoms, where does the case fall on the SLOS clinical spectrum?
  2. 2.What strategies do you recommend for managing specific sleep disturbances and nighttime wakings?
  3. 3.Are the self-injurious behaviors or irritability related to biochemical levels, and could a medication assessment help?
  4. 4.Should we conduct a specialized autism assessment that accounts for developmental age to better understand social communication needs?
  5. 5.How often should we monitor head circumference (microcephaly) and overall growth?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Keeping you on your toes: Smith-Lemli-Opitz Syndrome is an easily missed cause of developmental delays.

    Coupe S, Hertzog A, Foran C, et al.

    Clinical case reports 2023; (11(2)):e6920 doi:10.1002/ccr3.6920.

    PMID: 36814711
  2. 2

    Smith-Lemli-Opitz syndrome: Clinical, biochemical, and genetic insights with emerging treatment opportunities.

    Kritzer A, Dutta R, Pramparo T, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(7)):101450 doi:10.1016/j.gim.2025.101450.

    PMID: 40314187
  3. 3

    DHCR7 links cholesterol synthesis with neuronal development and axonal integrity.

    Miyazaki S, Shimizu N, Miyahara H, et al.

    Biochemical and biophysical research communications 2024; (712-713()):149932 doi:10.1016/j.bbrc.2024.149932.

    PMID: 38626530
  4. 4

    Alazami syndrome: Phenotypic expansion and clinical resemblance to Smith-Lemli-Opitz syndrome.

    Gana S, Plumari M, Rossi E, et al.

    American journal of medical genetics. Part A 2020; (182(11)):2722-2726 doi:10.1002/ajmg.a.61832.

    PMID: 32888391
  5. 5

    First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin.

    Aladia AH, Hamdan S, Alkheder A

    Oxford medical case reports 2024; (2024(11)):omae129 doi:10.1093/omcr/omae129.

    PMID: 39575090
  6. 6

    A Case of Smith-Lemli-Opitz Syndrome Diagnosed with Hypertrophic Pyloric Stenosis.

    Eren EE, Bilgin N, Urganci N, Kose G

    Sisli Etfal Hastanesi tip bulteni 2021; (55(2)):268-271 doi:10.14744/SEMB.2020.34651.

    PMID: 34349606
  7. 7

    Smith-Lemli-Opitz syndrome presenting as acute adrenal crisis in a child: a case report.

    Jayamanne C, Sandamal S, Jayasundara K, et al.

    Journal of medical case reports 2018; (12(1)):217 doi:10.1186/s13256-018-1738-4.

    PMID: 30092813
  8. 8

    Assessing Postnatal Mortality in Smith-Lemli-Opitz Syndrome.

    Selvaraman A, Rahhal S, Bianconi S, et al.

    American journal of medical genetics. Part A 2025; (197(2)):e63875 doi:10.1002/ajmg.a.63875.

    PMID: 39271956
  9. 9

    Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update.

    Thurm A, Tierney E, Farmer C, et al.

    Journal of neurodevelopmental disorders 2016; (8()):12 doi:10.1186/s11689-016-9145-x.

    PMID: 27053961
  10. 10

    Familial DHCR7 genotype presenting as a very mild form of Smith-Lemli-Opitz syndrome and lethal holoprosencephaly.

    Temple SEL, Sachdev R, Ellaway C

    JIMD reports 2020; (56(1)):3-8 doi:10.1002/jmd2.12155.

    PMID: 33204589
  11. 11

    Temporal changes in the brain lipidome during neurodevelopment of Smith-Lemli-Opitz syndrome mice.

    Li A, Hines KM, Ross DH, et al.

    The Analyst 2022; (147(8)):1611-1621 doi:10.1039/d2an00137c.

    PMID: 35293916
  12. 12

    A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.

    Wassif CA, Kratz L, Sparks SE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(3)):297-305 doi:10.1038/gim.2016.102.

    PMID: 27513191
  13. 13

    Traumatic Self-Inflicted Ventricular Laceration: A Case of Smith-Lemli-Opitz Syndrome in an Adult.

    Beuschel JJ, Ng GI, Abaraoha JC, Fortuna RJ

    Cureus 2024; (16(2)):e53613 doi:10.7759/cureus.53613.

    PMID: 38449995
  14. 14

    A Pilot Study of the Association of Markers of Cholesterol Synthesis with Disturbed Sleep in Smith-Lemli-Opitz Syndrome.

    Freeman KA, Olufs E, Tudor M, et al.

    Journal of developmental and behavioral pediatrics : JDBP 2016; (37(5)):424-30 doi:10.1097/DBP.0000000000000317.

    PMID: 27244299
  15. 15

    Cross-sectional analysis of expressive and receptive language skills in Smith-Lemli-Opitz syndrome (SLOS).

    Morris SM, Tierney E

    Journal of rare diseases (Berlin, Germany) 2025; (4(1)):56 doi:10.1007/s44162-025-00119-5.

    PMID: 40979443
  16. 16

    The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome.

    Tucci A, Ronzoni L, Arduino C, et al.

    BMC medical genetics 2016; (17()):22 doi:10.1186/s12881-016-0287-1.

    PMID: 26969503
  17. 17

    Smith-Lemli-Opitz Syndrome (SLOS)-Case Description and the Impact of Therapeutic Interventions on Psychomotor Development.

    Kozera N, Śmigiel R, Rozensztrauch A

    Journal of clinical medicine 2025; (14(23)) doi:10.3390/jcm14238569.

    PMID: 41375871

This page explains the varied symptoms of Smith-Lemli-Opitz Syndrome for educational purposes only. Always consult a geneticist or pediatrician for proper evaluation of symptoms and care management.

Get notified when new evidence is published on Smith-Lemli-Opitz syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.